<DOC>
	<DOCNO>NCT02003638</DOCNO>
	<brief_summary>This study look see niacin lessen atherosclerotic plaque inflammation favorably affect circulating level endothelial progenitor cell microparticles people atherosclerotic disease chronic statin therapy .</brief_summary>
	<brief_title>Assessment Of Vascular Health After Niacin Therapy ( AVANT )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Men age 55 year coronary artery disease woman age 65 year coronary artery disease OR Men age 45 year coronary artery disease carotid low extremity peripheral artery disease woman age 55 year coronary artery disease carotid low extremity peripheral artery disease . Subjects must statin monotherapy , define stable statin dose least 12 week , anticipate need titration study period Anxiety claustrophobia prohibit image History allergy intravenous contrast , iodine , shellfish Renal insufficiency History allergy severe intolerance niacin History diabetes mellitus elevate fast glucose Moderate severe gout Peptic ulcer disease Acute coronary syndrome , transient ischemic attack cerebrovascular accident , acute limb ischemia precede 12 month Heart failure unstable angina pectoris Use daily nonstatin lipidaltering therapy prior initiation study medication</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>